Diabetes Mellitus, Type 2: all 9,590 studies

Page 20 of 96. Open to participants first (1,331), then studies with results posted, then the rest; newest registration first within each.

• Physical Activity Behavior Change for Older Adults After Dysvascular AmputationCompletedNCT02738086Not applicableResults posted
• Safety and Efficacy Study of Tesofensine/Metoprolol Treatment in Subjects With Type 2 Diabetes MellitusCompletedNCT02737891Phase 2Results posted
• Efficacy in Controlling Glycaemia With Victoza® (Liraglutide) as add-on to Metformin vs. OADs as add-on to Metformin After up to 104 Weeks of Treatment in Subjects With Type 2 DiabetesCompletedNCT02730377Phase 4Results posted
• Study to Evaluate Safety and Efficacy of Dapagliflozin in Patients With Type 2 Diabetes Mellitus Aged 10-24 YearsCompletedNCT02725593Phase 3Results posted
• Mi Puente: My Bridge to Better Cardiometabolic Health and Well-BeingCompletedNCT02723019Not applicableResults posted
• Financial Incentives Telephone Education and Skills Trial in African Americans With Diabetes (FITEST)CompletedNCT02722499Not applicableResults posted
• An Open-label, Randomized, Crossover Study of Comparative Pharmacokinetics and Bioequivalence of Dapagliflozin + Metformin, 10 mg + 1000 mg Versus the Combined Use of Forxiga™, 10 mg and Two Glucophage® Long, ER Tablets, 500 mg Co-administered to Healthy Volunteers Under Standard Fed ConditionsCompletedNCT02722239Phase 1Results posted
• The LoBAG Diet and Type 2 Diabetes MellitusCompletedNCT02717078Not applicableResults posted
• Safety and Efficacy of Bexagliflozin as Monotherapy in Patients With Type 2 DiabetesCompletedNCT02715258Phase 3Results posted
• Impact of Medicaid Health Home on Patients With Diabetes in New York CityCompletedNCT02713321Results posted
• A Study of the GI Sleeve for the Treatment of Type 2 DiabetesCompletedNCT02709577Phase 1/2Results posted
• A Study of LY900014 in Participants With Type 2 Diabetes on Insulin Injection TherapyCompletedNCT02703337Phase 1Results posted
• A Trial Investigating the Cardiovascular Safety of Oral Semaglutide in Subjects With Type 2 DiabetesCompletedNCT02692716Phase 3Results posted
• Safety and Efficacy Study of Albiglutide Liquid Drug Product in Type 2 Diabetes MellitusCompletedNCT02683746Phase 3Results posted
• Renoprotective Effects of Dapagliflozin in Type 2 DiabetesCompletedNCT02682563Phase 4Results posted
• A Multi-Center, Randomized, Double-Blind, Phase III Trial to Evaluate the Safety and Efficacy of Saxagliptin Co-administered With Dapagliflozin Compared to Saxagliptin or Dapagliflozin All Given as add-on Therapy to Metformin in Subject With Type 2 DiabetesCompletedNCT02681094Phase 3Results posted
• Effect of Insulin Degludec Versus Insulin Glargine on Glycemic Variability in Patients With Type 2 Diabetes MellitusCompletedNCT02680457Phase 4Results posted
• An Observational Study of Patient Cohorts Who Previously Received Long-term Treatment With Pioglitazone or Placebo in Addition to Existing Antidiabetic MedicationsCompletedNCT02678676Results posted
• Interventional Study of Active Weight Management in Patients With Type 2 Diabetes and Obesity in Routine Clinical Practice During 12 Months.CompletedNCT02670928Phase 4Results posted
• A Pilot Study to Assess the Safety of Oral Insulin in Patients With Nonalcolholic Steatohepatitis (NASH)CompletedNCT02653300Phase 2Results posted
• Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart Twice Daily and Biphasic Insulin Aspart Twice Daily in Subjects With Type 2 Diabetes Mellitus Before, During and After RamadanCompletedNCT02648217Phase 3Results posted
• Efficacy and Safety of Semaglutide Versus Dulaglutide as add-on to Metformin in Subjects With Type 2 Diabetes.CompletedNCT02648204Phase 3Results posted
• 12-Week Study of DS-8500a in Subjects With Type 2 Diabetes Mellitus on MetforminCompletedNCT02647320Phase 2Results posted
• Effect of DPP4 Inhibition on VasoconstrictionCompletedNCT02639637Phase 4Results posted
• Measuring the Preferences of Patients With Type II Diabetes Using Best-worst Scaling and Discrete Choice ExperimentCompletedNCT02637622Results posted
• Measuring the Priorities of Patients With Type II Diabetes Using Likert Scale and Best-worst ScalingCompletedNCT02637609Results posted
• Empagliflozin and ACEi- Effects on Hyperfiltration: BETWEEN StudyCompletedNCT02632747Phase 2Results posted
• A Study to Evaluate the Efficacy and Safety of Ertugliflozin in Asian Participants With Type 2 Diabetes and Inadequate Glycemic Control on Metformin Monotherapy (MK-8835-012)CompletedNCT02630706Phase 3Results posted
• Remission Evaluation of a Metabolic Intervention in Type 2 Diabetes With Sitagliptin (REMIT-Sita)CompletedNCT02623998Phase 3Results posted
• Long-Term Safety Study of Canagliflozin (TA-7284) in Combination With Insulin in Patients With Type 2 Diabetes MellitusCompletedNCT02622113Phase 4Results posted
• ESR-15-11293 - Saxa/Dapa, Safety and Efficacy StudyCompletedNCT02613897Not applicableResults posted
• Effect of Dapagliflozin on Inflammation and Endothelial FunctionTerminatedNCT02608905Phase 4Results posted
• Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 DiabetesCompletedNCT02607865Phase 3Results posted
• A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Japanese Subjects With Type 2 Diabetes Mellitus.CompletedNCT02607306Phase 3Results posted
• Anti-Inflammatory Small Drug Adjunctive Therapy for Type 2 DiabetesCompletedNCT02597101Phase 2Results posted
• A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes MellitusCompletedNCT02597049Phase 3Results posted
• SGLT2 Inhibition and Stimulation of Endogenous Glucose Production: Protocol 2CompletedNCT02592421Phase 3Results posted
• Efficacy and Safety Study of Empagliflozin as add-on to Insulin in Japanese Patients With Type 2 Diabetes MellitusCompletedNCT02589639Phase 4Results posted
• Long-term Safety and Efficacy of Empagliflozin as Add on to GLP-1 RACompletedNCT02589626Phase 4Results posted
• A Study of U-500 Insulin (LY041001) in Participants With Type 2 DiabetesTerminatedNCT02588950Phase 1Results posted
• Effect of RVX000222 on Time to Major Adverse Cardiovascular Events in High-Risk T2DM Subjects With CADCompletedNCT02586155Phase 3Results posted
• Comparing Efficacy and Safety of Thrice Daily Versus Twice Daily NovoMix® 30 (Biphasic Insulin Aspart 30) in Subjects With Type 2 Diabetes Inadequately Controlled With Basal InsulinCompletedNCT02582242Phase 4Results posted
• Double-blind Sitagliptin Add-on Study in Japanese Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Ipragliflozin (MK-0431J-842)CompletedNCT02577016Phase 3Results posted
• Double-blind Ipragliflozin Add-on Study in Japanese Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Sitagliptin (MK-0431J-843)CompletedNCT02577003Phase 3Results posted
• Foxiga Korea Local Phase 4 StudyCompletedNCT02564926Phase 4Results posted
• Ipragliflozin Add-on Long-term Study in Japanese Participants With Type 2 Diabetes Mellitus on Sitagliptin (MK-0431J-849)CompletedNCT02564211Phase 3Results posted
• A Novel Positron Emission Tomography (PET) Approach to Measuring Myocardial MetabolismCompletedNCT02563834Not applicableResults posted
• A Multi-center 12-week Study of HMS5552 in T2DMCompletedNCT02561338Phase 2Results posted
• Remission Evaluation of a Metabolic Intervention in Type 2 Diabetes With ForxigaCompletedNCT02561130Phase 4Results posted
• An Administration Method Study of Human Regular U-500 Insulin (LY041001) in Participants With Type 2 Diabetes MellitusCompletedNCT02561078Phase 3Results posted
• Bexagliflozin Efficacy and Safety TrialCompletedNCT02558296Phase 3Results posted
• PowerUp for Health: A Diabetes Prevention Program for MenCompletedNCT02555631Not applicableResults posted
• A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On MetforminCompletedNCT02554877Phase 2Results posted
• A 24-week Open-Label, Phase 3b Trial With a 28-week Extension to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin Compared to Insulin Glargine in Subjects withType 2 Diabetes Who Have Glycemic Control on MetforminCompletedNCT02551874Phase 3Results posted
• Impact of Community Health Workers on Adherence to Therapy for Non-Communicable Chronic Disease in Chiapas, MexicoCompletedNCT02549495Results posted
• A Multiple-ascending-dose Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of MEDI0382 in Overweight and Obese Participants With Type 2 Diabetes MellitusCompletedNCT02548585Phase 1/2Results posted
• A Study to Evaluate the Effect of Dapagliflozin With and Without Saxagliptin on Albuminuria, and to Investigate the Effect of Dapagliflozin and Saxagliptin on HbA1c in Patients With Type 2 Diabetes and CKDCompletedNCT02547935Phase 2/3Results posted
• Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney DiseaseCompletedNCT02545049Phase 3Results posted
• Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes PatientsCompletedNCT02542631Not applicableResults posted
• Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and Diabetic Kidney DiseaseCompletedNCT02540993Phase 3Results posted
• Sitagliptin Therapy and Kinetics of Inflammatory MarkersCompletedNCT02536248Phase 3Results posted
• A 12/24-weeks, Open, Multi-centre, Phase IV Study on Safety and Efficacy of 2mg Exenatide Once Weekly (Bydureon) in T2DM Patients.CompletedNCT02533453Phase 4Results posted
• A Study to Assess the Addition of Sitagliptin to Metformin Compared With the Addition of Dapagliflozin to Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) and Mild Renal Impairment Who Have Inadequate Glycemic Control on Metformin With or Without a Sulfonylurea (MK-0431-838)CompletedNCT02532855Phase 3Results posted
• Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DMCompletedNCT02526524Phase 2Results posted
• Autologous Neo-Kidney Augment (NKA) in Patients With Type 2 Diabetes and Chronic Kidney Disease (CKD)TerminatedNCT02525263Phase 2Results posted
• Azilsartan Medoxomil in the Treatment of Essential Hypertension and Type 2 Diabetes in AsiaCompletedNCT02517866Phase 4Results posted
• Effect of 2-Week Nightly Moderate Hypoxia on Glucose Tolerance in Individuals With Type 2 DiabetesCompletedNCT02513641Not applicableResults posted
• A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal DiseaseCompletedNCT02512068Phase 3Results posted
• A Trial Comparing the Efficacy and Safety of Liraglutide 1.8 mg/Day to Liraglutide 0.9 mg/Day in Japanese Subjects With Type 2 Diabetes Mellitus.CompletedNCT02505334Phase 3Results posted
• A 104 Week Clinical Trial Comparing Long Term Glycaemic Control of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine Therapy in Subjects With Type 2 Diabetes MellitusCompletedNCT02501161Phase 3Results posted
• Heart Rate Variability in Response to Metformin ChallengeCompletedNCT02500628Phase 2Results posted
• A Study Evaluating the Effect of Albiglutide on Gallbladder Emptying in Healthy SubjectsCompletedNCT02496221Phase 4Results posted
• Phase II Safety and Efficacy Study of Oral ORMD-0801 in Patients With Type 2 Diabetes MellitusCompletedNCT02496000Phase 2Results posted
• A Preliminary Study of the Efficacy and Safety of MK-8521 for Type 2 Diabetes (MK-8521-004)TerminatedNCT02492763Phase 2Results posted
• Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Japanese Patients With Type 2 Diabetes MellitusCompletedNCT02489968Phase 3Results posted
• Long Term Daily Use of JARDIANCE® Tablets in Japanese Patients With Type 2 Diabetes MellitusCompletedNCT02489942Results posted
• Impact of a Virtual Diabetes Self-Care and Education Program on Diabetes-related Outcomes in Latinos With T2 DiabetesCompletedNCT02488785Not applicableResults posted
• FAMS Mobile Health Intervention for Diabetes Self-care SupportCompletedNCT02481596Not applicableResults posted
• Pilot Study to Evaluate the Safety and Efficacy of 5-ALA-SFC in Type II DiabetesCompletedNCT02481141Not applicableResults posted
• Vildagliptin Versus Dapagliflozin on GlucagonCompletedNCT02475070Phase 4Results posted
• Targeting Physical Activity to Improve Cardiovascular Health in Type 2 DiabetesCompletedNCT02473926Not applicableResults posted
• Efficacy and Safety of Dapagliflozin and Dapagliflozin Plus Saxagliptin in Combination With Metformin in Type 2 Diabetes Patients Compared With SulphonylureaCompletedNCT02471404Phase 4Results posted
• Linagliptin's Effect on CD34+ Stem CellsCompletedNCT02467478Phase 4Results posted
• Effect of Albiglutide, When Added to Standard Blood Glucose Lowering Therapies, on Major Cardiovascular Events in Subjects With Type 2 Diabetes MellitusCompletedNCT02465515Phase 4Results posted
• Dose-finding of Semaglutide Administered Subcutaneously Once Daily Versus Placebo and Liraglutide in Subjects With Type 2 DiabetesCompletedNCT02461589Phase 2Results posted
• Exenatide Inpatient Trial: A Randomized Controlled Pilot Trial on the Safety and Efficacy of Exenatide (Byetta®) Therapy for the Inpatient Management of Patients With Type 2 DiabetesCompletedNCT02455076Phase 4Results posted
• A Study to Compare Insulin Intensification of Biphasic Insulin Aspart 30 and Insulin Analogues (Insulin Glargine and Insulin Aspart) in Insulin naïve Type 2 Diabetic PatientsCompletedNCT02453685Phase 4Results posted
• Empagliflozin Add on to Linagliptin Study in Japanese Patient With Type 2 Diabetes MellitusCompletedNCT02453555Phase 3Results posted
• Glargine Versus NPH in Patients With Chronic Kidney DiseaseCompletedNCT02451917Phase 4Results posted
• A "Real World" Trial to Determine Efficacy and Health Outcomes of Toujeo (ACHIEVE CONTROL REAL LIFE STUDY PROGRAM)CompletedNCT02451137Phase 4Results posted
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of KQ-791 in Diabetes MellitusCompletedNCT02445911Phase 1Results posted
• Relationship Between Insulin Resistance and Statin Induced Type 2 Diabetes, and Integrative Personal Omics ProfilingCompletedNCT02437084Phase 4Results posted
• An Extension Protocol to Evaluate Dose Comparisons of Leucine-Metformin Combinations in Type 2 Diabetic PatientsCompletedNCT02435277Phase 2Results posted
• TAK-648 Multiple-Rising Dose Study in Healthy Japanese Participants and Non-Japanese Participants With Type 2 Diabetes MellitusCompletedNCT02430870Phase 1Results posted
• Effect of Dapagliflozin on 24-hour Blood Glucose in T2DM Patients Inadequately Controlled With Either Metformin Or InsulinCompletedNCT02429258Phase 4Results posted
• Effects of Dapagliflozin 10 mg on Insulin Resistance in Patients With Type 2 Diabetes MellitusCompletedNCT02426541Phase 4Results posted
• Longitudinal Phenotyping of Bariatric Surgery PatientsCompletedNCT02421055Results posted
• A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Basal-bolus Therapy in Subjects With Type 2 Diabetes MellitusCompletedNCT02420262Phase 3Results posted
• Memory Aid by Intranasal Insulin in Diabetes (MemAID)CompletedNCT02415556Phase 2Results posted
• A Study to Evaluate the Effect of Dapagliflozin on Blood Glucose Level and Renal Safety in Patients With Type 2 DiabetesCompletedNCT02413398Phase 3Results posted

← Diabetes Mellitus, Type 2 overview